Zerlasiran-A Small-Interfering RNA Targeting Lipoprotein(a): A Phase 2 Randomized Clinical Trial.
Nissen SE, Wang Q, Nicholls SJ, Navar AM, Ray KK, Schwartz GG, Szarek M, Stroes ESG, Troquay R, Dorresteijn JAN, Fok H, Rider DA, Romano S, Wolski K, Rambaran C.
Nissen SE, et al. Among authors: rider da.
JAMA. 2024 Dec 17;332(23):1992-2002. doi: 10.1001/jama.2024.21957.
JAMA. 2024.
PMID: 39556769
Clinical Trial.